Marizyme
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Marizyme generated cash of -$4,684,835, which is more than the previous year. Cash used in financing activities reached the amount of $4,322,435 last year. Net change in cash is therefore -$362,400.
Cash Flow
| 2014 | -741.80K | 272.32K | 469.49K |
|---|---|---|---|
| 2015 | -156.63K | -132.26K | 302.39K |
| 2016 | 160.51K | -1.18M | -162.99K |
| 2017 | 39.72K | 73.46K | 715.41K |
| 2018 | -218.90K | -1.38K | 168.78K |
| 2019 | -112.01K | -13K | 125K |
| 2020 | -3.22M | -148.65K | 6.27M |
| 2021 | -5.78M | 0 | 6.95M |
| 2022 | -10.85M | 0 | 7.29M |
| 2023 | -4.68M | 0 | 4.32M |
MRZM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 510.86K | 4.07M | 2.90M | 90 | 104 | 51.60K | 11.88K | 14.36K | 874 | 860 |
Operating activities | ||||||||||
Net income | -65.34M | -38.16M | -10.99M | -5.84M | -1.05M | -248.74K | -570.50K | -872.71K | -9.04M | -10.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 841.21K | 841.44K | 43.87K | 591.45K | 0 | 0 | 0 | 0 | 230K | 100K |
Stock-based compensation expense | 526.59K | 1.90M | 898.44K | 1.32M | 698.58K | 1 | 0 | 0 | 0 | 87K |
| Deferred income tax benefit | 526.59K | 1.90M | 898.44K | 1.32M | 698.58K | 1 | 0 | 0 | 0 | 87K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 7.03K | -53.15K | 36.29K | -40.58K | 0 | 0 | 320.95K | -16K | -928.65K | 349.73K |
Inventories | 190.71K | -193.21K | 33.98K | 127.12K | 0 | 0 | -319.94K | -503.12K | 0 | -259.74K |
Accounts payable | 2.19M | -228.68K | 968.78K | -155.66K | 197.43K | 18.55K | -179.66K | 269.25K | 352 | -38.17K |
Cash generated by operating activities | -4.68M | -10.85M | -5.78M | -3.22M | -112.01K | -218.90K | 39.72K | 160.51K | -156.63K | -741.80K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.18M | -132.26K | 0 |
Investments In Property Plant And Equipment | -2 | 0 | 0 | -148.65K | -13K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -132.26K | 272.32K |
Cash generated by investing activities | 0 | 0 | 0 | -148.65K | -13K | -1.38K | 73.46K | -1.18M | -132.26K | 272.32K |
Financing activities | ||||||||||
Common Stock Issued | 2.84M | 6.50M | 7.77B | 6.27M | 125K | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.21M | 786.93K | -1.13M | 0 | 0 | -75K | 0 | -346.53K | 346.53K | 0 |
Cash used in financing activities | 4.32M | 7.29M | 6.95M | 6.27M | 125K | 168.78K | 715.41K | -162.99K | 302.39K | 469.49K |
Net Change In Cash | -362.4K | -3.56M | 1.16M | 2.90M | -14 | -51.50K | 39.72K | -2.48K | 13.49K | 14 |
Cash at end of period | 148.46K | 510.86K | 4.07M | 2.90M | 90 | 104 | 51.60K | 11.88K | 14.36K | 874 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |